Oxford BioMedica plc (LON:OXB) insider Peter Nolan acquired 249,687 shares of the business’s stock in a transaction dated Monday, July 17th. The shares were bought at an average price of GBX 8 ($0.10) per share, with a total value of £19,974.96 ($25,874.30).

Oxford BioMedica plc (LON:OXB) traded down 11.24% during mid-day trading on Monday, reaching GBX 7.50. 4,421,406 shares of the company’s stock were exchanged. The firm’s market cap is GBX 231.30 million. The stock has a 50-day moving average of GBX 5.36 and a 200-day moving average of GBX 4.70. Oxford BioMedica plc has a 12 month low of GBX 2.98 and a 12 month high of GBX 11.25.

ILLEGAL ACTIVITY NOTICE: “Peter Nolan Buys 249,687 Shares of Oxford BioMedica plc (LON:OXB) Stock” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/07/17/peter-nolan-buys-249687-shares-of-oxford-biomedica-plc-lonoxb-stock.html.

A number of research analysts have commented on OXB shares. Shore Capital restated a “not rated” rating on shares of Oxford BioMedica plc in a research note on Thursday. N+1 Singer reaffirmed a “hold” rating and set a GBX 7.80 ($0.10) price objective on shares of Oxford BioMedica plc in a report on Thursday, July 6th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a GBX 13 ($0.17) price objective on shares of Oxford BioMedica plc in a report on Thursday.

Oxford BioMedica plc Company Profile

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.

Insider Buying and Selling by Quarter for Oxford BioMedica plc (LON:OXB)

Receive News & Ratings for Oxford BioMedica plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica plc and related companies with MarketBeat.com's FREE daily email newsletter.